iVeena completes its Series A financing

02 September 2015

iVeena announced that it has successfully completed its Series A financing. The iVeena financing was lead by the Park City Angels in cooperation with the Salt Lake Angels group. In addition, several nationally prominent ophthalmologists, physicians and the University of Utah Technology Venture Corporation contributed to filling out the round. “We are quite pleased that a broad base of individuals supported this financing and that iVeena now has adequate funding for the completion of its Phase I/2a clinical trial for post surgery cataract inflammation" said Jerry Simmons, iVeena CEO.